TOMI Environmental Launches Amazon Store For SteraMist Products

FREDERICK, Md., Sept. 13, 2021 (GLOBE NEWSWIRE) — TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination, is excited to launch a new Amazon store for select SteraMist products, including the recently launched SteraPak, in the USA.

TOMI has partnered with Orca Pacific (“Orca”), a leading full-service Amazon agency, to build and optimize TOMI’s Amazon store and to execute advertising initiatives for TOMI’s products. In partnering with Orca and launching an Amazon store, TOMI enables businesses and consumers to easily gain access to its leading hospital-healthcare and broad-spectrum disinfectant products.

By adding an optimized digital storefront on the leading e-commerce platform, TOMI is significantly expanding exposure and distribution for its newest product – the SteraPak. As an all-in-one disinfection solution, the SteraPak allows customers to use powerful, innovative SteraMist ionized Hydrogen Peroxide (iHP) in any setting, delivering highly maneuverable disinfection to the smallest of spaces. As the most cost effective SteraMist system, the SteraPak is primed to effectively target both businesses and consumer end users, making it an ideal flagship SteraMist product for sale on Amazon.

Dr. Halden Shane, CEO of TOMI states, “As we focus on growing our market penetration across multiple verticals, the launch of this elevated digital sales strategy complements our traditional sales methods and will be supported by our industry leading customer service. Amazon will provide a streamlined purchase process, and TOMI plans to continue executing its sales strategy by leveraging Amazon’s vast audience and platform.”

TOMI™ Environmental Solutions, Inc.: Innovating for a safer world^® 

TOMI™ Environmental Solutions, Inc. (NASDAQ:TOMZ) is a global decontamination and infection prevention company, providing environmental solutions for indoor surface disinfection through the manufacturing, sales and licensing of its premier Binary Ionization Technology^® (BIT^™) platform. Invented under a defense grant in association with the Defense Advanced Research Projects Agency (DARPA) of the U.S. Department of Defense, BIT^™ solution utilizes a low percentage Hydrogen Peroxide as its only active ingredient to produce a fog of ionized Hydrogen Peroxide (iHP^™). Represented by the SteraMist^® brand of products, iHP^™ produces a germ-killing aerosol that works like a visual non-caustic gas.

TOMI products are designed to service a broad spectrum of commercial structures, including, but not limited to, hospitals and medical facilities, cruise ships, office buildings, hotel and motel rooms, schools, restaurants, meat and produce processing facilities, military barracks, police and fire departments, and athletic facilities. TOMI products and services have also been used in single-family homes and multi-unit residences.

TOMI develops training programs and application protocols for its clients and is a member in good standing with The American Biological Safety Association, The American Association of Tissue Banks, Association for Professionals in Infection Control and Epidemiology, Society for Healthcare Epidemiology of America, America Seed Trade Association, and The Restoration Industry Association.

For additional information, please visit http://www.tomimist.com/ or contact us at info@tomimist.com.

Forward-Looking Statements

This press release contain forward-looking statements that are based on current expectations, estimates, forecasts and projections of future performance based on management’s judgment, beliefs, current trends, and anticipated product performance. These forward-looking statements include, without limitation, statements relating to sales strategies via Amazon store; the ability to grow and expand market shares for TOMI products; and support from customers of TOMI. Forward-looking statements involve risks and uncertainties that may cause actual results to differ materially from those contained in the forward-looking statements. These factors include, but are not limited to, the impact of COVID-19 pandemic on our business and customers; our ability to maintain and manage growth and generate sales, our reliance on a single or a few products for a majority of revenues; the general business and economic conditions; and other risks as described in our SEC filings, including our Annual Report on Form 10-K for the fiscal year ended December 31, 2020 filed by us with the SEC and other periodic reports we filed with the SEC. The information provided in this document is based upon the facts and circumstances known at this time. Other unknown or unpredictable factors or underlying assumptions subsequently proving to be incorrect could cause actual results to differ materially from those in the forward-looking statements. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance, or achievements. You should not place undue reliance on these forward-looking statements. All information provided in this press release is as of today’s date, unless otherwise stated, and we undertake no duty to update such information, except as required under applicable law.

INVESTOR RELATIONS CONTACT

John Nesbett/Jennifer Belodeau
IMS Investor Relations
jnesbett@imsinvestorrelations.com